VIA
DFTX

Virtus Investment Advisers’s Definium Therapeutics DFTX Stock Holding History

Virtus Investment Advisers’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$411K Buy
21,727
+529
+2% +$8.98K 0.11% 242
2025
Q4 		$284K Buy
21,198
+5,611
+36% +$69.4K 0.08% 265
2025
Q3 		$184K Buy
15,587
+2,706
+21% +$25.2K 0.05% 265
2025
Q2 		$83.6K Sell
12,881
-10,507
-45% -$69.1K 0.03% 408
2025
Q1 		$137K Buy
+23,388
New +$168K 0.04% 360

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus Investment Advisers's DFTX Position: Q1 2026 in Review

Virtus Investment Advisers increased its Definium Therapeutics (DFTX) stake by 2.5% in Q1 2026, buying an estimated $8.98K and bringing the position to 21,727 shares worth $411K. The position accounts for 0.11% of the portfolio, ranked #242.

Virtus Investment Advisers first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Virtus Investment Advisers held 21,727 shares of Definium Therapeutics worth $411K as of Q1 2026.
  • Virtus Investment Advisers bought 529 Definium Therapeutics shares in Q1 2026, an estimated $8.98K.
  • Definium Therapeutics made up 0.11% of Virtus Investment Advisers's portfolio in Q1 2026, its #242 holding.
  • Virtus Investment Advisers first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.